New C-COMPASS software opens spatial proteomics and lipidomics to non-coders
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of…
Poll: One in eight adults now using Ozempic, Wegovy or similar GLP-1 drugs
CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar…
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
Sudden cardiac death risk is sharply elevated in people with diabetes
The risk of sudden cardiac death is higher both for people with type 1 and type 2 diabetes,…
Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier…
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
Stopping GLP-1 drugs before pregnancy leads to more weight gain
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
Ozempic pill fails to slow Alzheimer’s disease
Ozempic warning: Experts warn of side effects from weight loss drug Experts are warning of the possible side…
Texture-based analysis of OCT images reveals early retinal changes in diabetes
Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people…
Drugs like Ozempic linked to annoying new side effect: study
New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many…
Higher stent complication risks found in patients with diabetes
Patients with diabetes have an increased risk of complications after stent implantation, according to a study from Karolinska…
Genetic signals reveal why erectile dysfunction develops and who is most at risk
New genomic evidence unmasks the biological pathways driving erectile dysfunction, linking cardiometabolic disease and addiction traits to ED…